"The remarkable success of VNS Therapy in the treatment of epilepsy has served as a platform for continued innovation. On July 15, 2005, after seven years of extensive study and clinical trials, VNS Therapy was approved by the FDA as a long-term adjunctive treatment for treatment-resistant depression." referenced, Cyberonics
"VNS Therapy™—the first non-drug therapy approved for epilepsy in 100 years
The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents over 12 years of age with partial onset seizures that are refractory to antiepileptic medications.
People who have medically refractory seizures are those who have tried two or more medications and are still not satisfied with seizure control, side effects, or their quality of life.
VNS Therapy has been proven in clinical studies to provide a safe and effective way to control seizures. The result for many people is an improvement in alertness and memory plus more energy and a better mood. And because it is not a drug, VNS Therapy has allowed many people to reduce the number or dosage of medications they take.
VNS Therapy does not typically cause side effects like depression, dizziness, confusion, weight gain, fatigue, insomnia and low energy. The most common side effects include hoarseness, a prickling feeling on the skin, shortness of breath, and increased coughing. And these side effects diminish over time. As with any surgery, there is a risk of infection." ...referenced,
Cyberonics
Request Information from Cyberonics
